Dapagliflozin reduces the amplitude of shortening and Ca(2+) transient in ventricular myocytes from streptozotocin-induced diabetic rats. (Record no. 24311785)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01489 a2200409 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517001303.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201509s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1573-4919 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1007/s11010-014-2262-5 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Hamouda, N N |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20150921 |
245 00 - TITLE STATEMENT | |
Title | Dapagliflozin reduces the amplitude of shortening and Ca(2+) transient in ventricular myocytes from streptozotocin-induced diabetic rats. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Molecular and cellular biochemistry |
Date of publication, distribution, etc. | Feb 2015 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 57-68 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Animals |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Benzhydryl Compounds |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Blood Glucose |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Calcium |
General subdivision | metabolism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Diabetes Mellitus, Experimental |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Glucose |
General subdivision | metabolism |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Glucosides |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Heart Ventricles |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Myocytes, Cardiac |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Patch-Clamp Techniques |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Rats |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Streptozocin |
General subdivision | toxicity |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sydorenko, V |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Qureshi, M A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Alkaabi, J M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Oz, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Howarth, F C |
773 0# - HOST ITEM ENTRY | |
Title | Molecular and cellular biochemistry |
Related parts | vol. 400 |
-- | no. 1-2 |
-- | p. 57-68 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1007/s11010-014-2262-5">https://doi.org/10.1007/s11010-014-2262-5</a> |
Public note | Available from publisher's website |
No items available.